Scholar Rock Holding Corp. (SRRK)
58.26
+0.06
(+0.10%)
USD |
NASDAQ |
Aug 25, 16:00
58.99
+0.73
(+1.25%)
After-Hours: 18:00
Scholar Rock Total Liabilities (Quarterly) : 269.76M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 269.76M |
| March 31, 2026 | 259.24M |
| December 31, 2025 | 158.78M |
| September 30, 2025 | 166.72M |
| June 30, 2025 | 106.75M |
| March 31, 2025 | 95.22M |
| December 31, 2024 | 106.29M |
| September 30, 2024 | 99.94M |
| June 30, 2024 | 93.24M |
| March 31, 2024 | 84.51M |
| December 31, 2023 | 85.82M |
| September 30, 2023 | 83.02M |
| June 30, 2023 | 82.40M |
| March 31, 2023 | 86.07M |
| December 31, 2022 | 97.93M |
| September 30, 2022 | 97.04M |
| June 30, 2022 | 94.62M |
| March 31, 2022 | 94.66M |
| Date | Value |
|---|---|
| December 31, 2021 | 132.37M |
| September 30, 2021 | 111.13M |
| June 30, 2021 | 115.40M |
| March 31, 2021 | 120.05M |
| December 31, 2020 | 127.54M |
| September 30, 2020 | 100.44M |
| June 30, 2020 | 74.19M |
| March 31, 2020 | 77.06M |
| December 31, 2019 | 83.48M |
| September 30, 2019 | 66.75M |
| June 30, 2019 | 67.96M |
| March 31, 2019 | 73.46M |
| December 31, 2018 | 74.71M |
| September 30, 2018 | 6.675M |
| June 30, 2018 | 7.366M |
| March 31, 2018 | 6.858M |
| December 31, 2017 | 5.927M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 523.54M |
| Shareholders Equity (Quarterly) | 253.78M |
| Debt to Equity Ratio | 0.8032 |
| Current Ratio | 7.021 |
| Net Debt Paydown Yield | -0.42% |